Bristol-Myers Squibb Company

BMYNYSEHealthcare● Active

$57.05

$-0.23(-0.39%)

Market Cap$116.5B

P/E Ratio—

52W High$62.89

52W Low$42.52

Avg Volume11.6M

Open$57.16

Beta0.24

Net Income Financials Revenue

Bristol-Myers Squibb Company (BMY) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BMY · net income · updated Jun 8, 2026

Core profitability metrics

BMY · net income · margin · TTM · CAGR

Net income was $7.05B for FY2025 (fiscal year ending 2025-12-31), up 178.8% year-over-year. Net profit margin was 14.6%. Based on available data, Bristol-Myers Squibb Company has been profitable since at least 2011.

FY2025 Net Income$7.05B▲ +178.8% YoY

Trailing 12M (TTM)$7.28Btrailing 4 quarters sum

Net Profit Margin14.6%$7.05B ÷ $48.19B

YoY Change+178.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · BMY net income history · BMY profit margin

Annual net income data

BMY · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$7.05B▲ +178.8%14.6%$48.19B

FY2024Loss−$8.95B▼ 211.5%-18.5%$48.30B

FY2023$8.03B▲ +26.8%17.8%$45.01B

FY2022$6.33B▼ 9.5%13.7%$46.16B

FY2021$6.99B▲ +177.8%15.1%$46.38B

Net income vs peers (Healthcare)

BMY vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Bristol-Myers Squibb CompanyYOU

BMY

$7.05B+178.8%14.6%

26%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Bristol-Myers Squibb Company (BMY) reported net income of $7.05B for FY2025 (fiscal year ending 2025-12-31), up 178.8% year-over-year. The net profit margin was 14.6% — meaning the company kept $0.15 of every dollar of revenue as profit.

Based on available data, Bristol-Myers Squibb Company has been profitable since at least 2011. Net income reached a peak of $8.03B in FY2023. Data available for 15 fiscal years.

Bristol-Myers Squibb Company's net profit margin was 14.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Bristol-Myers Squibb Company net worth" — the company's market capitalization is a separate figure from BMY net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BMY net income · 5 questions

Bristol-Myers Squibb Company is profitable. The company reported net income of $7.05B for FY2025, a net profit margin of 14.6%. Net income was up 178.8% year-over-year. Based on available data, Bristol-Myers Squibb Company has been profitable since at least 2011.

is BMY profitabledoes BMY make a profitBMY profitabilityBMY profitable company

▸ Source: FMP /income-statement · GAAP · Bristol-Myers Squibb Company · Bristol-Myers Squibb Company SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026